Financhill
Back

TransMedics Group 10K Form

Buy
65

TMDX
TransMedics Group

Last Price:
166.00
Seasonality Move:
-0.45%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TMDX News And Ratings

See the #1 stock for the next 7 days that we like better than TMDX

TMDX Financial Statistics

Sales & Book Value

Annual Sales: $241.62M
Cash Flow: $1.96M
Price / Cash Flow: 0
Annual Sales: $5.70
Price / Book: 27.36

Profitability

EPS (TTM): 0.04000
Net Income (TTM): $3M
Gross Margin: $154.09M
Return on Equity: 1.98%
Return on Assets: 0.42%

TransMedics Group Earnings Forecast

Key TransMedics Group Financial Ratios

  • The Gross Profit Margin over the past 8 years for TMDX is 63.77%.
  • The Selling, General & Administrative Expenses for TMDX have been equal to 49.48% of Gross Profit Margin.
  • The Research & Development expenses have been 26.18% of Revenue.
  • The Interest Expense is -43.12% of Operating Income.
  • The Net Earning history of TMDX is -10.36% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 5 years.

TransMedics Group Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: TMDX
CUSIP: 89377M
Website: transmedics.com

Debt

Debt-to-Equity Ratio: 2.67
Current Ratio: 9.37
Quick Ratio: 8.17

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 84.55

TMDX Technical Analysis vs Fundamental Analysis

Buy
65
TransMedics Group (TMDX) is a Buy

Is TransMedics Group a Buy or a Sell?

  • TransMedics Group stock is rated a Buy
    The current TransMedics Group [TMDX] share price is $155.95. The Score for TMDX is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.